ZKB/PUT/ROCHE GS/215/0.025/28.06.24 Share Price

Warrant

ROGVPZ

CH1305138930

Delayed Swiss Exchange 08:50:00 13/06/2024 pm IST
0.01 CHF -33.33% Intraday chart for ZKB/PUT/ROCHE GS/215/0.025/28.06.24
1 month-80.00%
3 months-81.82%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer ZKB
ROGVPZ
ISINCH1305138930
Date issued 21/02/2024
Strike 215 CHF
Maturity 28/06/2024 (2 Days)
Parity 40 : 1
Emission price 0.15 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 0.15 CHF
Lowest since issue 0.01 CHF
Spread 0.019 CHF
Spread %95.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Warrants
  3. ROGVPZ Warrant